Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Cash: 2020-2024

Historic Change in Cash for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to $9.8 million.

  • Pyxis Oncology's Change in Cash rose 86.07% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year change of. This contributed to the annual value of $9.8 million for FY2024, which is 105.78% up from last year.
  • Pyxis Oncology's Change in Cash amounted to $9.8 million in FY2024, which was up 105.78% from -$169.6 million recorded in FY2023.
  • In the past 5 years, Pyxis Oncology's Change in Cash ranged from a high of $268.1 million in FY2021 and a low of -$169.6 million during FY2023.
  • For the 3-year period, Pyxis Oncology's Change in Cash averaged around -$85.1 million, with its median value being -$95.6 million (2022).
  • Its Change in Cash has fluctuated over the past 5 years, first spiked by 2,425.08% in 2021, then plummeted by 135.64% in 2022.
  • Pyxis Oncology's Change in Cash (Yearly) stood at -$11.5 million in 2020, then surged by 2,425.08% to $268.1 million in 2021, then slumped by 135.64% to -$95.6 million in 2022, then plummeted by 77.53% to -$169.6 million in 2023, then soared by 105.78% to $9.8 million in 2024.